While biopharma was dominated by COVID-19, which prompted a surge of research and business activity, the industry also saw developments that will position it for further...
Six months after rebranding from BHE, Panalgo has won a contract to supply the European Medicines Agency (EMA) The post EMA will use Panalgo software for...
In this GEN webinar, sponsored by Thermo Fisher Scientific, our presenters will highlight upstream and downstream solutions across the AAV production workflows. The post Scalable AAV...
From step counters and active video games to apps for exercisers and tech-enabled gear, there are a lot of ways to combine your workouts with your...
Investors AlleyNIO Stock Price On The Move Nio Inc. (NIO) stock price popped on the EV boom, and on news of even more record deliveries. NIO...
Nostalgia is a powerful emotion, but we shouldn't let it take over our lives.
About a year after Eli Lilly absorbed Dermira in a $1 billion buyout, the dermatology company’s co-founders are licensing back three inflammatory disease programs they helped...
Boston area biotech Werewolf Therapeutics launched in late 2019 with the goal of chasing novel immune system modulators to eradicate solid tumors. Just over a year...
Louis van de Wiel, Vice President, Site Head EU Manufacturing, Kite, a Gilead Company, reveals the complexity that The post Why cell therapy manufacture is a...
Review of the life histories of RNA viruses, their genetics, and the compounds that could disrupt them offers hope for curtailment of future pandemics Credit: Illustration:...
There’s a strong feeling growing among investors – of relief – that the new year will feature lower volatility than 2020. That along would be enough...
In the first of a two part series, IQVIA’s Sarah Rickwood covers nine key trends and events that The post Nine for 2021: The COVID-19 legacy...
The companies created a combined antibody discovery and development platform for Charles River Labs clients that integrates Distributed Bio’s libraries and optimization technologies with Charles River’s...
Study looks at treating severe COVID-19 with umbilical-cord derived mesenchymal stem cells Credit: University of Miami Health System University of Miami Miller School of Medicine researchers...
‘Like smart bomb technology to the lung,’ randomized trial shows Credit: © Dr. Camillo Ricordi Dr. Camilo Ricordi, director of the Diabetes Research Institute (DRI) and...
Shares of ViewRay dropped 13% in Tuesday's pre-market session after the company announced the pricing of a public offering of 10.31 million shares of common stock...
BioSpace reviewed the top 10 novel drug approvals of 2020, loosely based on projected earnings in the upcoming years.
Credit: IDM All prediabetes is not the same: in people in the preliminary stages of type 2 diabetes, there are six clearly distinguishable subtypes, which differ...
Containment during the pandemic has contributed to a recognition of the importance of public space as a gathering place and an essential tool to meet the...
An unprecedented pandemic did not stop the US stock market from finishing 2020 on a high note. The S&P 500 ended a highly volatile year at...
Sage Therapeutics received $1.525 billion from Biogen under the earlier announced collaboration and license agreement to jointly develop treatments for depression and other neurological disorders. Per...
RedHill Biopharma Ltd. said that preliminary data results from the US Phase 2 study of its opaganib administered in patients hospitalized with COVID-19 pneumonia demonstrated positive...
Lexicon Pharmaceuticals has initiated patient dosing in the Phase 2 clinical study (called RELIEF-PHN 1) of LX9211 for the treatment of post-herpetic neuralgia. Shares closed 3.3%...
AI-powered insurance company Lemonade announced on Thursday that it ended 2020 with over one million active customers. However, shares dropped 5.7% on the last trading day...
2020 was a year to remember, for so many reasons, but there is one reason that might not be obvious: it was the year of the...
Getting Out Before The Crash... Authored by Doug Casey via InternationalMan.com, International Man: Markets have extreme emotions. They can go from irrational exuberance—where it seems everyone...
Incyte and biotechnology company Cellenkos on Dec. 30 announced a partnership to assess the combination of ruxolitinib (Jakafi) and CK0804, cord blood-derived T-regulatory cells, in patients...
The brain is surprisingly changeable.
Quanterix announced that the US FDA has provided EUA for its Simoa Semi-Quantitative SARS-CoV-2 IgG Antibody Test
These tickers changing hands for less than $5 per share either draw investors in with their high return potential or send them running.